| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |